Publications
Export 24 results:
Auteur Title Type [ Année
Filtres: Auteur is Alzheimer's Disease Neuroimaging Initiative [Enlever les filtres]
Amyloid-dependent and amyloid-independent effects of Tau in individuals without dementia.. Ann Clin Transl Neurol. 8(10):2083-2092.
.
2021. Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.. Alzheimers Dement.
.
2021. Hippocampal subfield volumes across the healthy lifespan and the effects of MR sequence on estimates.. Neuroimage. 233:117931.
.
2021. Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.. Am J Geriatr Psychiatry. 29(4):319-332.
.
2021. A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia.. Gigascience. 8(5)
.
2019. Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology.. Alzheimers Dement. 15(9):1160-1171.
.
2019. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.. Neurology. 90(11):e932-e939.
.
2018. CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.. Alzheimers Dement.
.
2018. variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.. Neurol Genet. 4(1):e216.
.
2018. A comparison of accurate automatic hippocampal segmentation methods.. Neuroimage. 155:383-393.
.
2017. Identifying incipient dementia individuals using machine learning and amyloid imaging.. Neurobiol Aging. 59:80-90.
.
2017. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.. Neurology. 88(6):569-576.
.
2017. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.. Neurology. 88(19):1814-1821.
.
2017. The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database.. Alzheimers Dement (N Y). 3(1):107-113.
.
2017. Synergistic interaction between amyloid and tau predicts the progression to dementia.. Alzheimers Dement. 13(6):644-653.
.
2017. Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry.. Hum Brain Mapp. 38(6):2875-2896.
.
2017. .
2016. .
2016.
Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.. Front Aging Neurosci. 7:242.
.
2015. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.. Mol Psychiatry. 20(7):867-73.
.
2015. Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
.
2015. Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.. Neurobiol Aging. 36 Suppl 1:S23-31.
.
2015. .
2014. .
2014.